Last reviewed · How we verify
NCT03717233
Assistive ExoSkeletons to Enable Wearable Rehabilitation Robotics
NA trial testing Exoskeleton in Diabetic Foot Ulcer in 40 participants. Completed in 17 October 2019.
17 October 2019
Quick facts
| Lead sponsor | Results Group LLC |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 40 |
| Start date | 18 October 2018 |
| Primary completion | 17 October 2019 |
| Estimated completion | 17 October 2019 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Exoskeleton
Conditions studied
- Diabetic Foot Ulcer — all drugs for Diabetic Foot Ulcer →
- Diabetic Foot Ulcer Associated With Type II Diabetes Mellitus — all drugs for Diabetic Foot Ulcer Associated With Type II Diabetes Mellitus →
Sponsor
Results Group LLC
Who can join
18 and older, any sex, with Diabetic Foot Ulcer or Diabetic Foot Ulcer Associated With Type II Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Study will evaluate the use of lower-limb assistive exo-skeletons worn on the ankle and foot. Participants will wear the exo-skeletons and walk in a safe environment. Measurements will be taken to determine how the exo-skeletons affect the pressure on the feet of people with diabetic foot ulcer and how they walk.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03717233
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exoskeleton
Trials testing the same drug.
- NCT07323147 — Clinical Efficacy of Exoskeleton Robot-Assisted Rehabilitation on Lower Limb Functional Recovery in Elderly Patients Wit · NA · enrolling by invitation
- NCT04978467 — SPiRE Maestro Hand Exoskeleton for Rehabilitation Post Stroke · NA · withdrawn
- NCT06028529 — Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease · NA · recruiting
- NCT06222398 — Exoskeleton Use With In Home Functional Activities · terminated
- NCT06041100 — What Are the Effects of a Bilateral Hip Exoskeleton During Daily Use by 65+ Adults? · NA · completed
Other recruiting trials for Diabetic Foot Ulcer
Currently open trials in the same condition.
- NCT07161830 — Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers · NA · recruiting
- NCT07396376 — Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers · Phase 1, PHASE2 · recruiting
- NCT07291817 — Intermittent Negative Pressure for Patients With Diabetic Foot Ulcers (INPRESS) Study · NA · recruiting
- NCT07209358 — EDX110 Randomized Control Trial for Treatment of DFUs · NA · recruiting
- NCT06938685 — Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03717233 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Results Group LLC
- Last refreshed: 2 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03717233.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing